Celltrion Archives -

Celltrion gears up for subcutaneous infliximab launch in Europe

https://pharmaphorum.com/views-analysis-market-access/celltrion-gears-up-for-subcutaneous-infliximab-launch-in-europe/

https://pharmaphorum.com/news/first-rituxan-biosimilar-truxima-set-to-makes-its-debut-in-us/

Celltrion/Teva’s Herceptin biosimilar approved in US

https://pharmaphorum.com/news/celltrion-tevas-herceptin-biosimilar-approved-in-us/

Sandoz axes filing of US Rituxan biosimilar

https://pharmaphorum.com/news/sandoz-axes-filing-of-us-rituxan-biosimilar/

Celltrion/Teva Rituxan biosimilar edges closer to US approval

https://pharmaphorum.com/news/celltrion-teva-rituxan-biosimilar-edges-closer-to-us-approval/

Celltrion’s Rituxan biosimilar gets glowing review ahead of key meeting

https://pharmaphorum.com/news/celltrions-rituxan-biosimilar-gets-glowing-review-ahead-of-key-meeting/

Biosimilars underused in rheumatoid arthritis on the NHS – experts

https://pharmaphorum.com/news/biosimilars-underused-rheumatoid-arthritis-nhs-experts/

Celltrion hopes to outdo inflammatory disease rivals with SC infliximab

https://pharmaphorum.com/news/celltrion-hopes-to-outdo-inflammatory-disease-rivals-with-sc-infliximab/

FDA rejects Teva/Celltrion biosimilars

https://pharmaphorum.com/news/fda-rejects-teva-celltrion-biosimilars/

Search